Skip to content

Staar Surgical STAA Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale at other companies

10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$25M
GitLab logo
GitLabGTLB
$218.82M+33.8%
Repligen logo
RepligenRGEN
$66M
Fulton Financial logo
Fulton FinancialFULT
$35.15M+78.2%
ServisFirst Bancshares logo
ServisFirst BancsharesSFBS
$59.34M-27.7%
Erasca, Inc. logo
Erasca, Inc.ERAS
$58.55M+30.1%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+92.0%
Enterprise value$1.35B+117%
P/S+2.3×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's proceeds from maturities, prepayments and calls of debt securities, available-for-sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's proceeds from maturities, prepayments and calls of debt securities, available-for-sale?
Staar Surgical (STAA) reported proceeds from maturities, prepayments and calls of debt securities, available-for-sale of $5.46M in Q1 2026.
How has Staar Surgical's proceeds from maturities, prepayments and calls of debt securities, available-for-sale changed year-over-year?
Staar Surgical's proceeds from maturities, prepayments and calls of debt securities, available-for-sale decreased by 89.3% year-over-year, from $51.15M to $5.46M.
What is the long-term trend for Staar Surgical's proceeds from maturities, prepayments and calls of debt securities, available-for-sale?
Over 3 years (2022 to 2025), Staar Surgical's proceeds from maturities, prepayments and calls of debt securities, available-for-sale has grown at a 93.6% compound annual growth rate (CAGR), from $17.12M to $124.15M.
What does proceeds from maturities, prepayments and calls of debt securities, available-for-sale mean?
This measures cash inflows resulting from the natural maturity or early redemption of debt securities held in the investment portfolio. It indicates the recurring cash generation from the company's fixed-income investment strategy.